BACKGROUND: Atrial fibrillation (AF) is heterogeneous at the clinical and molecular levels. Association studies have reported that common single-nucleotide polymorphisms in KCNE1 and SCN5A may predispose to AF. In this study, we tested the hypothesis that specific AF-associated genotypes confer variation on the appearance of AF assessed by analysis of fibrillatory rate of the atria. METHODS AND RESULTS: Twenty-six nonrelated patients (21 males, mean age 55+/-12 years) with persistent lone AF (median AF duration 5 weeks) not taking class I or III antiarrhythmic drugs were studied. Fibrillatory rate was obtained by spatiotemporal QRST cancellation and time-frequency analysis of the index surface ECG. Genotypes at the AF-associated loci in KCNE1 (S38G) and SCN5A (H558R) were determined by direct DNA sequencing. The atrial fibrillatory rate was 418+/-50 fibrillations per minute (range, 336 to 521) in the study cohort. Carriers of the 38GG KCNE1 genotype (n=13) had significantly lower fibrillatory rates (392+/-36 versus 443+/-49 fibrillations per minute, P0.006) compared to those with GS or SS genotype (n=13). Six patients (23%) with fibrillatory rates >450 fibrillations per minute, all had either the GS or SS genotype (Chi2 P0.008). In contrast, both the heterozygeous and homozygeous SCN5A H558R polymorphism had no effect on fibrillatory rate. There were no significant associations between fibrillatory rate and clinical (age, gender, AF duration, drug treatment) or echocardiographic (left atrial diameter, left ventricular ejection fraction) variables. In multivariable regression analysis, the KCNE1 S38G genotype (SS/GS coded 0, GG coded 1) was the only independent predictor of fibrillatory rate (beta = -0.437, P = 0.006) with a SE of the estimate of 44 fibrillations per minute. CONCLUSIONS: This study suggests that atrial fibrillatory rate obtained from the surface ECG is at least in part determined by KCNE1 (S38G) genotype, implying that this variant exerts functional effects on atrial electrophysiology. This intermediate ECG phenotype may be useful for elaborating genetic influences on AF mechanisms and identifying subsets of patients for variability in AF susceptibility or response to therapies.
BACKGROUND:Atrial fibrillation (AF) is heterogeneous at the clinical and molecular levels. Association studies have reported that common single-nucleotide polymorphisms in KCNE1 and SCN5A may predispose to AF. In this study, we tested the hypothesis that specific AF-associated genotypes confer variation on the appearance of AF assessed by analysis of fibrillatory rate of the atria. METHODS AND RESULTS: Twenty-six nonrelated patients (21 males, mean age 55+/-12 years) with persistent lone AF (median AF duration 5 weeks) not taking class I or III antiarrhythmic drugs were studied. Fibrillatory rate was obtained by spatiotemporal QRST cancellation and time-frequency analysis of the index surface ECG. Genotypes at the AF-associated loci in KCNE1 (S38G) and SCN5A (H558R) were determined by direct DNA sequencing. The atrial fibrillatory rate was 418+/-50 fibrillations per minute (range, 336 to 521) in the study cohort. Carriers of the 38GG KCNE1 genotype (n=13) had significantly lower fibrillatory rates (392+/-36 versus 443+/-49 fibrillations per minute, P0.006) compared to those with GS or SS genotype (n=13). Six patients (23%) with fibrillatory rates >450 fibrillations per minute, all had either the GS or SS genotype (Chi2 P0.008). In contrast, both the heterozygeous and homozygeous SCN5AH558R polymorphism had no effect on fibrillatory rate. There were no significant associations between fibrillatory rate and clinical (age, gender, AF duration, drug treatment) or echocardiographic (left atrial diameter, left ventricular ejection fraction) variables. In multivariable regression analysis, the KCNE1S38G genotype (SS/GS coded 0, GG coded 1) was the only independent predictor of fibrillatory rate (beta = -0.437, P = 0.006) with a SE of the estimate of 44 fibrillations per minute. CONCLUSIONS: This study suggests that atrial fibrillatory rate obtained from the surface ECG is at least in part determined by KCNE1 (S38G) genotype, implying that this variant exerts functional effects on atrial electrophysiology. This intermediate ECG phenotype may be useful for elaborating genetic influences on AF mechanisms and identifying subsets of patients for variability in AF susceptibility or response to therapies.
Authors: Andreas Bollmann; Karl-Heinz Binias; Ines Toepffer; Jochen Molling; Christoph Geller; Helmut U Klein Journal: Am J Cardiol Date: 2002-11-01 Impact factor: 2.778
Authors: Sorin Lazar; Sanjay Dixit; Francis E Marchlinski; David J Callans; Edward P Gerstenfeld Journal: Circulation Date: 2004-11-08 Impact factor: 29.690
Authors: Daniela Husser; David S Cannom; Anil K Bhandari; Martin Stridh; Leif Sörnmo; S Bertil Olsson; Andreas Bollmann Journal: Europace Date: 2007-04-30 Impact factor: 5.214
Authors: Mehran Firouzi; Hemanth Ramanna; Bart Kok; Habo J Jongsma; Bobby P C Koeleman; Pieter A Doevendans; W Antoinette Groenewegen; Richard N W Hauer Journal: Circ Res Date: 2004-08-05 Impact factor: 17.367
Authors: Jonathan C Makielski; Bin Ye; Carmen R Valdivia; Matthew D Pagel; Jielin Pu; David J Tester; Michael J Ackerman Journal: Circ Res Date: 2003-09-18 Impact factor: 17.367
Authors: Andreas Bollmann; Daniela Husser; Reiko Steinert; Martin Stridh; Leif Soernmo; S Bertil Olsson; Daniela Polywka; Jochen Molling; Christoph Geller; Helmut U Klein Journal: J Cardiovasc Electrophysiol Date: 2003-10
Authors: Zenawit Girmatsion; Peter Biliczki; Ina Takac; Christin Schwerthelm; Stefan H Hohnloser; Joachim R Ehrlich Journal: PLoS One Date: 2011-11-04 Impact factor: 3.240
Authors: Alberto Zullo; Giulia Frisso; Nicola Detta; Berardo Sarubbi; Emanuele Romeo; Angela Cordella; Carlos G Vanoye; Raffaele Calabrò; Alfred L George; Francesco Salvatore Journal: Int J Mol Sci Date: 2017-07-27 Impact factor: 5.923